Literature DB >> 23246019

Pulmonary 3He magnetic resonance imaging of childhood asthma.

Robert V Cadman1, Robert F Lemanske, Michael D Evans, Daniel J Jackson, James E Gern, Ronald L Sorkness, Sean B Fain.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) with (3)He does not require ionizing radiation and has been shown to detect regional abnormalities in lung ventilation and structure in adults with asthma, but the method has not been extended to children with asthma. Measurements of regional lung ventilation and microstructure in subjects with childhood asthma could advance our understanding of disease mechanisms.
OBJECTIVE: We sought to determine whether (3)He MRI in children can identify abnormalities related to the diagnosis of asthma or prior history of respiratory illness.
METHODS: Forty-four children aged 9 to 10 years were recruited from a birth cohort at increased risk of asthma and allergic diseases. For each subject, a time-resolved 3-dimensional image series and a 3-dimensional diffusion-weighted image were acquired in separate breathing maneuvers. The numbers and sizes of ventilation defects were scored, and regional maps and statistics of average (3)He diffusion lengths were calculated.
RESULTS: Children with mild-to-moderate asthma had lower average root-mean-square diffusion length (X(rms)) values (P = .004), increased regional SD of diffusion length values (P = .03), and higher defect scores (P = .03) than those without asthma. Children with histories of wheezing illness with rhinovirus infection before the third birthday had lower X(rms) values (P = .01) and higher defect scores (P = .05).
CONCLUSION: MRI with (3)He detected more and larger regions of ventilation defect and a greater degree of restricted gas diffusion in children with asthma compared with those seen in children without asthma. These measures are consistent with regional obstruction and smaller and more regionally variable dimensions of the peripheral airways and alveolar spaces.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246019      PMCID: PMC3563846          DOI: 10.1016/j.jaci.2012.10.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  34 in total

1.  Spirometric pulmonary function in healthy preschool children.

Authors:  H Eigen; H Bieler; D Grant; K Christoph; D Terrill; D K Heilman; W T Ambrosius; R S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Hyperpolarized 3He MR lung ventilation imaging in asthmatics: preliminary findings.

Authors:  T A Altes; P L Powers; J Knight-Scott; G Rakes; T A Platts-Mills; E E de Lange; B A Alford; J P Mugler; J R Brookeman
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

3.  Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge.

Authors:  Saba Samee; Talissa Altes; Patrick Powers; Eduard E de Lange; Jack Knight-Scott; Gary Rakes; John P Mugler; Jonathan M Ciambotti; Bennet A Alford; James R Brookeman; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

Review 4.  Is forced expiratory volume in one second the best measure of severity in childhood asthma?

Authors:  Joseph D Spahn; Reuben Cherniack; Keith Paull; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2004-01-30       Impact factor: 21.405

Review 5.  Standardisation of the measurement of lung volumes.

Authors:  J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

6.  Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes--initial experience.

Authors:  Michael Salerno; Eduard E de Lange; Talissa A Altes; Jonathon D Truwit; James R Brookeman; John P Mugler
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

7.  Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy.

Authors:  James E Gern; Matthew S Martin; Kelly A Anklam; Kunling Shen; Kathy A Roberg; Kirstin T Carlson-Dakes; Kiva Adler; Stephanie Gilbertson-White; Rebekah Hamilton; Peter A Shult; Carol J Kirk; Douglas F Da Silva; Sarah A Sund; Michael R Kosorok; Robert F Lemanske
Journal:  Pediatr Allergy Immunol       Date:  2002-12       Impact factor: 6.377

Review 8.  The childhood origins of asthma (COAST) study.

Authors:  Robert F Lemanske
Journal:  Pediatr Allergy Immunol       Date:  2002       Impact factor: 6.377

9.  Estimation of cancer mortality associated with repetitive computed tomography scanning.

Authors:  Pim A de Jong; John R Mayo; Kamran Golmohammadi; Yasutaka Nakano; Maarten H Lequin; Harm A W M Tiddens; John Aldrich; Harvey O Coxson; Don D Sin
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

10.  MR imaging of diffusion of (3)He gas in healthy and diseased lungs.

Authors:  B T Saam; D A Yablonskiy; V D Kodibagkar; J C Leawoods; D S Gierada; J D Cooper; S S Lefrak; M S Conradi
Journal:  Magn Reson Med       Date:  2000-08       Impact factor: 4.668

View more
  18 in total

Review 1.  3He diffusion MRI in human lungs.

Authors:  Jason C Woods; Mark S Conradi
Journal:  J Magn Reson       Date:  2018-04-26       Impact factor: 2.229

2.  Safety of repeated hyperpolarized helium 3 magnetic resonance imaging in pediatric asthma patients.

Authors:  Nanae Tsuchiya; Mark L Schiebler; Michael D Evans; Robert V Cadman; Ronald L Sorkness; Robert F Lemanske; Daniel J Jackson; Nizar N Jarjour; Loren C Denlinger; Sean B Fain
Journal:  Pediatr Radiol       Date:  2020-01-24

Review 3.  Early-life viral infections and the development of asthma: a target for asthma prevention?

Authors:  Daniel J Jackson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-04

4.  Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis.

Authors:  Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland
Journal:  Pediatr Radiol       Date:  2016-08-05

5.  Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT.

Authors:  Robert P Thomen; Ajay Sheshadri; James D Quirk; Jim Kozlowski; Henry D Ellison; Rhonda D Szczesniak; Mario Castro; Jason C Woods
Journal:  Radiology       Date:  2014-08-19       Impact factor: 11.105

Review 6.  The role of hyperpolarized 129xenon in MR imaging of pulmonary function.

Authors:  Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain
Journal:  Eur J Radiol       Date:  2016-09-16       Impact factor: 3.528

Review 7.  Early origins of chronic obstructive lung diseases across the life course.

Authors:  Liesbeth Duijts; Irwin K Reiss; Guy Brusselle; Johan C de Jongste
Journal:  Eur J Epidemiol       Date:  2014-12-24       Impact factor: 8.082

8.  Advances in pediatric asthma in 2013: coordinating asthma care.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2014-03       Impact factor: 10.793

Review 9.  Functional imaging of the lungs with gas agents.

Authors:  Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain
Journal:  J Magn Reson Imaging       Date:  2015-07-27       Impact factor: 4.813

10.  Viral bronchiolitis in young rats causes small airway lesions that correlate with reduced lung function.

Authors:  Ronald L Sorkness; Renee J Szakaly; Louis A Rosenthal; Ruth Sullivan; James E Gern; Robert F Lemanske; Xin Sun
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.